7 Results for "

MAGL-IN-1

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "MAGL-IN-1" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-111538
CAS No.: 2324160-91-8
Purity:  99.78%
Target:  

MAGL

Research Areas:  

Cancer

MAGL-IN-1 is a potent, selective, reversible and competitive inhibitor of MAGL, with an IC50 of 80 nM. MAGL-IN-1 exhibits anti-proliferative effects against human breast, colorectal, and ovarian cancer cells. MAGL-IN-1 blocks MAGL in cell-based as well as in vivo assays [1].
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N2512
CAS No.: 589-68-4
1-Monomyristin acts as an insecticide, enzyme inhibitor, antibacterial and antifungal agent, with an IC50 of 18 μM against rat FAAH and an IC50 of 32 μM against rat MAGL. 1-Monomyristin inhibits 2-oleoylglycerol hydrolysis via MAGL. 1-Monomyristin suppresses the growth of Staphylococcus aureus, Aggregatibacter actinomycetemcomitans and Candida albicans. 1-Monomyristin is lethal to brine shrimp . 1-Monomyristin exhibits marginal cytotoxicity against prostate cancer cells. 1-Monomyristin is applicable to research related to bacterial infections, fungal infections, renal cancer, prostate adenocarcinoma and pancreatic cancer [1] .
loading...
    loading...
Cat. No.: HY-111538R
CAS No.: 2324160-91-8
Research Areas:  

Cancer

MAGL-IN-1 (Standard) is the analytical standard of MAGL-IN-1 (HY-111538). This product is intended for research and analytical applications. MAGL-IN-1 is a potent, selective, reversible and competitive inhibitor of MAGL, with an IC50 of 80 nM. MAGL-IN-1 exhibits anti-proliferative effects against human breast, colorectal, and ovarian cancer cells. MAGL-IN-1 blocks MAGL in cell-based as well as in vivo assays [1].
loading...
    loading...
Cat. No.: HY-143263
Target:  

FAAH MAGL

Research Areas:  

Neurological Disease

FAAH/MAGL-IN-1 (compound SIH 3) is a potent FAAH and MAGL inhibitor with IC50s of 31 nM and 29 nM, respectively. FAAH/MAGL-IN-1 has the potential for the research of neuropathic pain [1].
loading...
    loading...
Cat. No.: HY-173369
Target:  

PROTACs MAGL MDM-2/p53

Research Areas:  

Neurological Disease Cancer

PROTAC MAGL degrader-1 is an orally active, moderately blood-brain barrier permeable bifunctional PROTAC (DC50: 60.28 nM) that possesses MAGL degradation activity alongside MDM2 inhibitory activity. PROTAC MAGL degrader-1 recruits E3 ubiquitin ligase MDM2 to mediate ubiquitination of MAGL and subsequent proteasomal degradation. PROTAC MAGL degrader-1 blocks the interaction between MDM2 and P53 and upregulates the expression of tumor suppressor protein P53. PROTAC MAGL degrader-1 is applicable for research on glioblastoma stem cells, melanoma and breast cancer [1].
loading...
    loading...
Cat. No.: HY-168145
CAS No.: 2411570-42-6
Target:  

MAGL

Research Areas:  

Cancer

MAGL-IN-19 (compund 7o) is a highly potent and selective MAGL inhibitor .
loading...
    loading...
Cat. No.: HY-173370
CAS No.: 2725023-11-8
Research Areas:  

Others

MAGL Ligand-Linker Conjugate 1 is a conjugate of the MAGL ligand and the linker. MAGL Ligand-Linker Conjugate 1 can be used for synthesis of PROTAC degrader PROTAC MAGL degrader-1 (HY-173369) [1].
loading...
    loading...